Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Phillips

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 12, 1998
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupA N Phillips, C Katlama, S Barton, et al.
AIDS Research and Human Retroviruses|July 2, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfectionA Mocroft, A N Phillips, V Soriano, et al.
AIDS (London, England)|July 23, 1999
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV MedicineA Mocroft, S Barry, C A Sabin, et al.
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
AIDS (London, England)|June 1, 1994
A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study GroupA N Phillips, F Antunes, G Stergious, et al.
HIV Medicine|December 17, 2009
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppressionV Cambiano, F C Lampe, A J Rodger, et al.
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
AIDS (London, England)|September 13, 2000
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV MedicineA Mocroft, H Devereux, S Kinloch-de-Loes, et al.
AIDS (London, England)|June 16, 2001
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavirO Kirk, A Mocroft, C Pradier, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 12, 1998
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupA N Phillips, C Katlama, S Barton, et al.
AIDS Research and Human Retroviruses|July 2, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfectionA Mocroft, A N Phillips, V Soriano, et al.
AIDS (London, England)|July 23, 1999
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV MedicineA Mocroft, S Barry, C A Sabin, et al.
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
AIDS (London, England)|June 1, 1994
A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study GroupA N Phillips, F Antunes, G Stergious, et al.
HIV Medicine|December 17, 2009
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppressionV Cambiano, F C Lampe, A J Rodger, et al.
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
AIDS (London, England)|September 13, 2000
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV MedicineA Mocroft, H Devereux, S Kinloch-de-Loes, et al.
AIDS (London, England)|June 16, 2001
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavirO Kirk, A Mocroft, C Pradier, et al.
Pageof 24